SCHEMBL28034366

SCHEMBL28034366

COCCCCc1c(C(=O)O)nnn1-c1ccc(CN)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.40
REN P00797 1/20 0.40
HTT P42858 2/20 0.39
TP53 P04637 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
POLB P06746 1/20 0.36
PTGS2 P35354 2/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
ALDH1A1 P00352 3/20 0.35
MAPT P10636 3/20 0.35
LMNA P02545 2/20 0.35
HPGD P15428 1/20 0.35
GFER P55789 1/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA4 P22748 1/20 0.35
CA9 Q16790 1/20 0.35
ALOX12 P18054 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28034294 0.89 PPARG (0.42) PPARGRENHTTTP53SMN1; SMN2
SCHEMBL2221448 0.87 CA1 (0.44) PPARGRENHTTTP53SMN1; SMN2
SCHEMBL2219018 0.87 HTT (0.52) PPARGRENHTTTP53SMN1; SMN2
SCHEMBL2221627 0.86 PTGS2 (0.46) PPARGRENHTTTP53SMN1; SMN2
SCHEMBL2219586 0.86 SMN1; SMN2 (0.47) PPARGRENHTTTP53SMN1; SMN2
SCHEMBL2217094 0.86 PTGS2 (0.46) PPARGRENHTTL3MBTL1POLB
SCHEMBL2220649 0.81 ALDH1A1 (0.42) PPARGRENHTTTP53SMN1; SMN2
SCHEMBL2223484 0.81 HSD11B1 (0.47) PPARGRENHTTTP53SMN1; SMN2
SCHEMBL2218506 0.81 GAA (0.51) PPARGRENHTTSMN1; SMN2NPC1
SCHEMBL2218858 0.81 ALDH1A1 (0.43) PPARGRENHTTTP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103373985-B Heterocyclic compounds and their use TAKEDA PHARMACEUTICAL CO.,LTD. (JP) 2015-10-28 CN disclosed